Why on earth would the absence of "chemo brain" not be studied and approval on that basis applied for if it appeared to be statistically significant? Even with failure to reduce cancer a drug like that could be approved.
How was this never mentioned before? This seems like a huge indication on its own. Even going back and reviewing the cancer data and putting together a poster presentation for a medical conference, seems like this could be easily done.
News 
Market Data 
Discover 
